Chlorzoxazone
Product Images NDC 51862-340

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Chlorzoxazone (NDC 51862-340). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayne Pharma Commercial Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Chlorzoxazone 01)

FDA Label Image

Principal Display Panel (375 mg Tablet Bottle Label)

Principal Display Panel (375 mg Tablet Bottle Label)
This is a description of Chlorzoxazone Tablets, USP, containing 375mg of chlorzoxazone per tablet. The tablets are intended for prescription use only and should be kept in a light-resistant container with a child-resistant closure. The recommended storage temperature range is 20° to 25° C. The dosage should be as prescribed by a professional. The tablets are a product of Taiwan and manufactured by Mayne Pharma in Greenville, NC. The NDC number is 51862-338-01.*
FDA Label Image

Principal Display Panel (500 mg Tablet Bottle Label)

Principal Display Panel (500 mg Tablet Bottle Label)
Each tablet of this medication contains 500mg of chlorzoxazone. The medication should be stored in a tightly closed, child-resistant container at controlled room temperature between 20° and 25° C. This bulk container is not meant for household use and should be kept out of the reach of children. The accompanying prescribing information should be consulted for recommended dosages. The product is manufactured in Taiwan by Mayne Pharma and is available in a bottle containing 100 tablets.*
FDA Label Image

Principal Display Panel (750 mg Tablet Bottle Label)

Principal Display Panel (750 mg Tablet Bottle Label)
This is a medication containing chlorzoxazone, USP 750 mg, with instructions to dispense and store it in tight, light-resistant containers with child-resistant closure, and to keep it out of reach of children. It should be stored at room temperature and the usual dosage should be followed as per the accompanying prescribing information. The product is manufactured in Taiwan by Mayne Pharma and is available in a bulk container with 100 tablets.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.